Xanomeline, a cholinergic agonist, was initially evaluated for the treatment of Alzheimer’s disease and schizophrenia. Reference standards of Xanomeline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Xanomeline
Catalogue No.:PA 24 0110000
CAS :
Molecular Formula : C14H23N3OS
Molecular Weight : 281.42
N-Desmethyl Xanomeline
Catalogue No.:PA 24 0111000
Molecular Formula : C13H21N3OS
Molecular Weight : 267.39
3-(Hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole
Catalogue No.:PA 24 0111001
Molecular Formula : C13H17N3OS
Molecular Weight : 263.36
3-(4-(Hexyloxy)-1,2,5-thiadiazol-3-yl)-1-methylpyridin-1-ium Iodide
Catalogue No.:PA 24 0111002
Molecular Formula : C14H20IN3OS
Molecular Weight : 405.3
3-(Heptyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole
Catalogue No.:PA 24 0111003
Molecular Formula : C15H25N3OS
Molecular Weight : 295.45
Xanomeline N-Oxide
Catalogue No.:PA 24 0111004
Molecular Formula : C14H23N3O2S
Molecular Weight : 297.42
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
